About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue 04-02-2024 at 4:05 PM EDT Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024 03-27-2024 at 8:30 AM EDT Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference 02-22-2024 at 4:05 PM EST VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Adaptive Biotechnologies Business Update Apr 2, 2024 at 4:30 PM EDT Listen to webcast TD Cowen 44th Annual Healthcare Conference Mar 4, 2024 at 2:10 PM EST Listen to webcast Adaptive Biotechnologies Fourth Quarter Financial Results Feb 14, 2024 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Q4 2023 Earnings Presentation 1.6 MB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Apr 16, 2024 2:37 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
